Hematologic Malignancy
📧 Sign up to get email alerts when something new happens for Hematologic Malignancy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor [NA]
A completed clinical trial evaluated haploidentical (half-matched) related donor stem cell transplantation using Killer Immunoglobulin-like …
-
CLINICAL_TRIALS other · 2024-11-27Clinical Trial Update: Critical Care Outcomes of Hematologic Oncology Patients
An update on a clinical trial evaluating critical care outcomes in patients with hematologic malignancies undergoing stem cell transplantati…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Remote Temperature Data for Early Detection of Febrile Neutropenia
This clinical trial update reports on a completed study evaluating remote temperature data for early detection of febrile neutropenia in pat…
-
CLINICAL_TRIALS withdrawal · 2024-10-31Clinical Trial Update: Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors [Phase 2]
Phase 2 trial of itacitinib for treating steroid-refractory immune-related adverse events from immune checkpoint inhibitors has been withdra…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products
Long-term follow-up results are reported for patients who received gene therapy or gene-marked products across several conditions, including…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Viral Specific T Cell Therapy for COVID-19 Related Pneumonia [EARLY_Phase 1]
An early Phase 1 trial of viral-specific T cell therapy for COVID-19-related pneumonia has completed, evaluating safety and feasibility in p…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer
This clinical trial update examines distress associated with COVID-19 and the use of telehealth in supportive-care patients with advanced ca…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm [Phase 4]
Phase 4 study evaluating individualized first maintenance doses of voriconazole using a multiparametric algorithm for invasive aspergillosis…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy [Phase 2]
This Phase 2 trial assesses the safety and immunogenicity of the Moderna COVID-19 vaccine (mRNA-1273) in patients with solid tumors and hema…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation [Phase 2]
A Phase 2 study evaluating the safety and efficacy of PBCLN-010 in combination with PBCLN-014 in participants receiving allogeneic hematopoi…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies [Phase 1]
Phase 1 study evaluating safety, tolerability and preliminary efficacy of an erythrocyte-anchored PD-1 conjugate in patients with advanced m…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies [Phase 1]
Phase 1 dose-escalation study update evaluating the safety of PBCAR19B in participants with CD19-expressing hematologic malignancies.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Seen and Be Heard: Ensuring Fair Cancer Care for All Children
This is a clinical trial update for a pediatric cancer study sponsored by Great Ormond Street Hospital; the trial is currently not yet recru…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: TRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic Shock [Phase 3]
A Phase 3 clinical trial evaluating transfusion in patients with hematologic malignancies resuscitated from septic shock has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy [Phase 1, Phase 2]
A completed Phase 1/2 study evaluated risk-adapted donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in chi…
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: Characteristics and Outcomes of Patients With Hematological Malignancies
An update describing the characteristics of patients with hematologic malignancies in a trial that is currently not recruiting.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Genetics in the Progression of Nephropathies
A clinical study sponsored by Ospedale San Raffaele is investigating how genetics influence the progression of various kidney-related diseas…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Immunity to Infection in Healthy Participants and Participants With Cancer
This clinical trial update describes an ongoing study evaluating immunity to influenza and COVID-19 in healthy participants and in patients …
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating antibiotic therapy or immunoglobulin strategies in patients with hematologic malignancies and hy…
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis [Phase 2]
Phase 2 trial evaluating infliximab with intravenous immunoglobulin for steroid-refractory pneumonitis in patients with hematologic or solid…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Early Neutropenic Fever De-escalation of Antibiotics Study [Phase 3]
Phase 3 trial exploring de-escalation of antibiotics for early neutropenic fever in hematologic malignancy.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation [Phase 2]
Phase 2 clinical trial update evaluating tocilizumab for prevention of graft failure and graft-versus-host disease in haplo-cord transplanta…
-
CLINICAL_TRIALS research · 2023-08-22Clinical Trial Update: Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy [Phase 1, Phase 2]
A phased pharmacokinetic study of the Ledipasvir/Sofosbuvir combination in children with chronic hepatitis C and concurrent hematologic mali…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Expressive Helping for Stem Cell Transplant Patients [Phase 3]
A Phase 3 clinical trial update for Expressive Helping in stem cell transplant patients with hematologic malignancies; the study is complete…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant [Phase 2]
Phase 2 trial updating the use of tocilizumab with GVHD prophylaxis to prevent acute and chronic GVHD after allogeneic stem cell transplant;…